AJOB Neuroscience.

Deep Brain Stimulation as a Probative Biology: Scientific Inquiry and the Mosaic Device

Building upon an earlier critique of the Food and Drug Adminstration (FDA) granting of a humanitarian device exemption for deep brain stimulation in treatment-resistant obsessive compulsive disorder, this article considers how we regulate and finance DBS. It suggests that these devices are mosaic in nature: both potentially therapeutic and probative and that their dual roles need to be appreciated to maximize their therapeutic and investigational potential.

View Full Text

Bookmark the permalink.

Comments are closed.

Volume 3, Issue 1
January 2012